Breaking News Instant updates and real-time market news.

GDI

Gardner Denver

$27.32

0.31 (1.15%)

, FTV

Fortive

$64.85

0.62 (0.97%)

17:02
10/09/19
10/09
17:02
10/09/19
17:02

Gardner Denver names Emily Weaver CFO

Gardner Denver (GDI) announced the appointment of Emily A. Weaver as Senior Vice President and Chief Financial Officer effective December 1, 2019. As Senior Vice President and CFO, Weaver will oversee all finance and accounting, including controllership, tax, treasury, planning, and investor relations, as well as information technology, and will report directly to Vicente Reynal, Chief Executive Officer. Weaver joins Gardner Denver from Fortive Corporation (FTV) where she is currently its Chief Accounting Officer. Weaver will succeed Neil Snyder, Gardner Denver's current CFO, who is leaving to pursue other opportunities. Snyder will remain CFO until the transition and will continue in an advisory capacity for a mutually agreed period.

GDI

Gardner Denver

$27.32

0.31 (1.15%)

FTV

Fortive

$64.85

0.62 (0.97%)

  • 24

    Oct

GDI Gardner Denver
$27.32

0.31 (1.15%)

05/01/19
FBCO
05/01/19
NO CHANGE
Target $36
FBCO
Outperform
Gardner Denver price target raised to $36 from $31 at Credit Suisse
Credit Suisse analyst John Walsh raised his price target for Gardner Denver to $36 from $31 on accelerating transformation. The analyst reiterates an Outperform rating on the shares.
05/07/19
UBSW
05/07/19
DOWNGRADE
UBSW
Neutral
Gardner Denver downgraded to Neutral from Buy at UBS
05/07/19
UBSW
05/07/19
DOWNGRADE
Target $38
UBSW
Neutral
UBS downgrades Gardner Denver to Neutral, says shares due for 'breather'
UBS analyst Damian Karas downgraded Gardner Denver to Neutral from Buy while raising his price target for the shares to $38 from $31. The shares are due for a "breather" following the recent run as benefits from the Ingersoll-Rand (IR) deal are now largely priced in, Karas tells investors in a research note.
05/07/19
05/07/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Fluor (FLR) downgraded to Neutral from Buy at Goldman Sachs with analyst Jerry Revich seeing an unclear medium-term margin outlook amid the company's CEO transition and further project writedowns in Q1. 2. Gardner Denver (GDI) downgraded to Neutral from Buy at UBS with analyst Damian Karas downgraded saying the shares are due for a "breather" following the recent run. 3. Boeing (BA) downgraded to Equal Weight from Overweight at Barclays with analyst David Strauss expecting the recovery of 737 Max production to take longer than expected. 4. Discover (DFS) downgraded to Perform from Outperform at Oppenheimer with analyst Dominick Gabriele seeing limited upside in the shares following the rally year-to-date now that his estimates are in-line with the consensus. 5. Cambrex (CBM) downgraded to Outperform from Strong Buy at First Analysis with analyst Steven Schwartz saying the company's valuation multiple is now in-line with peers following the recent share price appreciation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
FTV Fortive
$64.85

0.62 (0.97%)

06/03/19
COWN
06/03/19
DOWNGRADE
Target $65
COWN
Underperform
Fortive downgraded to Underperform from Market Perform at Cowen
Cowen analyst Joseph Giordano downgraded Fortive to Underperform from Market Perform and lowered his price target for the shares to $65 from $75.
06/03/19
06/03/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Infinera (INFN) downgraded to Underweight from Neutral at JPMorgan with analyst Samik Chatterjee saying he sees a "heightened level of near-term and medium-term risks from the much more moderate level" of capex spending from cable customers. 2. Cree (CREE) downgraded to Market Perform from Outperform at BMO Capital with analyst Ambrish Srivastava saying he believes Cree is executing solidly on its transformation but finds the stock's risk/reward profile as fairly balanced at current levels. 3. Fortive (FTV) downgraded to Underperform from Market Perform at Cowen. 4. Big Lots (BIG) double downgraded to Underperform from Buy at BofA/Merrill with analyst Jason Haas saying the company's outlook for the rest of the year may be too optimistic and could be cut further. 5. Emerald Expositions Events (EEX) downgraded to Neutral from Buy at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/26/19
RAJA
07/26/19
NO CHANGE
RAJA
Fortive price target lowered to $84 from $88 at Raymond James
Raymond James analyst Brian Gesuale reiterated an Outperform rating on Fortive, but lowered his price target on shares to $84 from $88 following the company's "mixed" Q2 earnings results and lowered guidance. However, the analyst is reiterating his Outperform based on the company "hitting the mark" on the core parts of the firm's thesis with "M&A successes, increased exposure to key secular themes and strong annual cash generation."
08/05/19
GDHS
08/05/19
DOWNGRADE
GDHS
Hold
Fortive downgraded to Hold from Buy at Gordon Haskett
Gordon Haskett analyst John Inch downgraded Fortive to Hold from Buy.

TODAY'S FREE FLY STORIES

F

Ford

$9.04

-0.025 (-0.28%)

12:00
10/23/19
10/23
12:00
10/23/19
12:00
Options
Large pre-earnings calendar spread in Ford ahead of earnings »

Large pre-earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

TXN

Texas Instruments

$120.29

-8.32 (-6.47%)

11:50
10/23/19
10/23
11:50
10/23/19
11:50
Options
Aggressive post-earnings put seller in Texas Instruments »

Aggressive post-earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBTC

Bitcoin Investment Trust

$0.00

(0.00%)

, FB

Facebook

$185.39

3.12 (1.71%)

11:48
10/23/19
10/23
11:48
10/23/19
11:48
Periodicals
Bitcoin falls amid Zuckerberg testimony on Facebook's Libra, Bloomberg says »

Bloomberg's Claire…

GBTC

Bitcoin Investment Trust

$0.00

(0.00%)

FB

Facebook

$185.39

3.12 (1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

SPY

SPDR S&P 500 ETF Trust

$299.50

0.47 (0.16%)

, SPX

S&P 500

$0.00

(0.00%)

11:47
10/23/19
10/23
11:47
10/23/19
11:47
General news
President Trump says lifting sanctions on Turkey with ceasefire to be permanent »

President Trump announced…

SPY

SPDR S&P 500 ETF Trust

$299.50

0.47 (0.16%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZS

Zscaler

$41.57

0.84 (2.06%)

11:45
10/23/19
10/23
11:45
10/23/19
11:45
Options
Zscaler call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

11:45
10/23/19
10/23
11:45
10/23/19
11:45
General news
Treasury's $20 B 2-year FRN was awarded at a high discount margin of 0.300% »

Treasury's $20 B…

SDC

SmileDirectClub

$10.19

0.685 (7.21%)

11:39
10/23/19
10/23
11:39
10/23/19
11:39
Recommendations
SmileDirectClub analyst commentary  »

Guggenheim says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

HEXO

Hexo

$2.54

-0.05 (-1.93%)

11:39
10/23/19
10/23
11:39
10/23/19
11:39
Hot Stocks
Breaking Hot Stocks news story on Hexo »

Hexo Corp trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 12

    Nov

  • 12

    Nov

11:37
10/23/19
10/23
11:37
10/23/19
11:37
General news
2-Yr FRN Note Auction Bid/Cover data reported »

2-Yr FRN Note Auction…

11:37
10/23/19
10/23
11:37
10/23/19
11:37
General news
2-Yr FRN Note Auction Total Amount data reported »

2-Yr FRN Note Auction…

SAVE

Spirit Airlines

$37.33

0.08 (0.21%)

, EADSY

Airbus

$0.00

(0.00%)

11:33
10/23/19
10/23
11:33
10/23/19
11:33
Periodicals
Spirit Airlines near deal for as many as 100 Airbus A320 jets, Reuters says »

Spirit Airlines (SAVE) is…

SAVE

Spirit Airlines

$37.33

0.08 (0.21%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 13

    Nov

KAMN

Kaman

$58.38

-0.2 (-0.34%)

11:33
10/23/19
10/23
11:33
10/23/19
11:33
Hot Stocks
Kaman executes long term agreement with Winglet Technology »

Kaman Composites…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

TWTR

Twitter

$38.93

0.11 (0.28%)

11:32
10/23/19
10/23
11:32
10/23/19
11:32
Earnings
Fly Intel: What to watch in Twitter earnings report »

Twitter (TWTR) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

ABMD

Abiomed

$175.20

4.45 (2.61%)

, ABT

Abbott

$81.49

0.95 (1.18%)

11:29
10/23/19
10/23
11:29
10/23/19
11:29
Recommendations
Trial for potential Abiomed competition pushed back a year, says Piper Jaffray »

This morning, the primary…

ABMD

Abiomed

$175.20

4.45 (2.61%)

ABT

Abbott

$81.49

0.95 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 13

    Nov

HEMA

HemaCare Corp.

$0.00

(0.00%)

11:27
10/23/19
10/23
11:27
10/23/19
11:27
Periodicals
Breaking Periodicals news story on HemaCare Corp. »

HemaCare Corp. working…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMD

Abiomed

$175.20

4.45 (2.61%)

, ABT

Abbott

$81.52

0.98 (1.22%)

11:27
10/23/19
10/23
11:27
10/23/19
11:27
Hot Stocks
Abiomed jumps after Abbott heart pump trial pushed back one year »

An update today on…

ABMD

Abiomed

$175.20

4.45 (2.61%)

ABT

Abbott

$81.52

0.98 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 13

    Nov

MGNX

MacroGenics

$9.87

-1.17 (-10.60%)

, ZYME

Zymeworks

$30.25

-0.26 (-0.85%)

11:26
10/23/19
10/23
11:26
10/23/19
11:26
Recommendations
MacroGenics, Zymeworks analyst commentary  »

MacroGenics price target…

MGNX

MacroGenics

$9.87

-1.17 (-10.60%)

ZYME

Zymeworks

$30.25

-0.26 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 06

    Nov

TRU

TransUnion

$82.71

2.31 (2.87%)

11:26
10/23/19
10/23
11:26
10/23/19
11:26
Conference/Events
TransUnion management to meet with SunTrust »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 19

    Nov

CVM

CEL-SCI

$7.35

(0.00%)

11:25
10/23/19
10/23
11:25
10/23/19
11:25
Options
Cel Sci call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRCG

NRC Group

$13.00

(0.00%)

, ECOL

US Ecology

$66.75

0.245 (0.37%)

11:25
10/23/19
10/23
11:25
10/23/19
11:25
Conference/Events
US Ecology to host special shareholder meeting »

Special Shareholder…

NRCG

NRC Group

$13.00

(0.00%)

ECOL

US Ecology

$66.75

0.245 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 31

    Oct

SNAP

Snap

$13.24

-0.76 (-5.43%)

11:19
10/23/19
10/23
11:19
10/23/19
11:19
Hot Stocks
Snap says DOJ, SEC no longer pursuing investigations of IPO disclosures »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
10/23/19
10/23
11:17
10/23/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
10/23/19
10/23
11:16
10/23/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$184.34

2.07 (1.14%)

11:05
10/23/19
10/23
11:05
10/23/19
11:05
Hot Stocks
Facebook shares up 1.6% as CEO testifies on Capitol Hill »

Facebook CEO Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

CNC

Centene

$48.49

-0.28 (-0.57%)

11:05
10/23/19
10/23
11:05
10/23/19
11:05
Options
Centene call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.